Dr. Anita Gupta, is an Anesthesiologist, Physician, Pharmacist Drug Expert, and Author of 50 Studies Every Anesthesiologist Should Know.

• Recognized as an international drug expert, physician-pharmacist executive, thought leader, and author, connecting business, clinical medicine, and healthcare innovation, appointed physician at Johns Hopkins

• Featured on the cover of Philadelphia Inquirer for noting the illicit opioid drug trade

• Nominated by HealthyWomen as a candidate for US FDA Commissioner

• Drug expert on medical cases involving: Tiger Woods, Bill Cosby,  Jolie, Prince, Lady Gaga, Beyonce, among others

• Rutgers University featured alum for breakthrough initiatives on drug policy and the opioid crisis

• Thought leader for the Washington Post, Forbes, CNN, on emerging threats, including the Coronavirus crisis, the Opioid crisis, Zika crisis, catastrophic train crash in center city Philadelphia, Pennsylvania, US

• Author of 50 Studies Every Anesthesiologist Should Know, Pharmacology in Anesthetic Practice and Interventional Pain Medicine, reviewed by the International Anesthesia Research Society

• Recognized as one of the first appointed woman physician anesthesiologist to pioneer the expansion of the first opioid overdose antidote, naloxone, at the U.S. FDA appointed in collaboration with leaders at the American Society of Anesthesiologists and former Co-Chair the American Society of Anesthesiologist Committee on Prescription Opioid Abuse   

• Distinguished Fellow of the National Academies of Practice, Patient Advocacy Awardee

• Public service appointee at the Food and Drug Administration and the Department of Defense

• National Academies of Science’s Global Forum Member, Author of top 50 commentaries on the transformation of the patient experience, and digital transformation in healthcare

• Named amongst the Top in Healthcare in Philly Biz magazine

• Featured Author at She Roars Women’s Conference at Princeton University

• Voted at Harvard Business School as Graduation Speaker and Strategy Finalist

• Harvard Business School Healthcare Alumni Association Regional Director and Co-President of the Alumnae Harvard Network for Women

• Recognized as one of the first physician-pharmacist alumnae of Princeton University School of Public and International Affairs and Harvard University School of Business 

Focus

• Digital Transformation, Future of Health

• Healthcare, Public Policy, International Affairs

• Palliative, Oncology, Rare Diseases

• FDA Regulatory Guidelines

• Clinical Trials, Drug Development

• Chronic, Regional, Acute Pain

• Health Innovation

Expertise

• Anesthesiology & Pain Medicine

• Pandemic Crisis and Emergency Response

• Global Health, COVID-19 Vaccines

• Surgical and Anesthetic Perioperative Care

• Pharmacology and Therapeutics Development

• Biotechnology and Neurosciences

• Social Determinants of Healthcare and Equitable Innovation

Residency & Fellowship

• Johns Hopkins University, Anesthesiology and Critical Care Medicine, Anesthesiology Pain Fellowship, Baltimore, MD

• National Institutes of Health, National Heart, Lung, and Blood Institute, Clinical Research Scientist Track, Bethesda, MD

• Georgetown University Hospital, Washington D.C., Anesthesiology Residency

• Georgetown University Hospital, Washington D.C., Chief Resident

Professional Education

• Princeton University, Masters in Public Policy and Certificate in Health Health Policy (MPP, HHP)

• Harvard Business School, Harvard Alumnae, General Management Program (GMP and Women on Corporate Boards)

• Massachusetts Institute of Technology, Controlled Drug Release Technology, CRT, Professional Education

• Mayday Foundation Fellowship, Washington D.C.

• Wharton School of Business, Total Leadership Program, the University of Pennsylvania, Philadelphia, PA